Page results
-
Patient information about the Cognitive Behavioural Therapy for Insomnia (CBTi) at the RLHIM.
-
Functional dyspepsia and gastroparesis often co-exist. There are good treatment pathways for managing the symptoms associated with these conditions.
-
Information and advice on sleeping to help prevent sudden infant deaths or cot death.
-
This page explains how to hand express your colostrum. It is for mothers/birthing parents who will have a baby on the neonatal unit.
-
This clinic specialises in the diagnosis and treatment of adult patients with allergic conditions.
-
The Insomnia and Behavioural Sleep Medicine Clinic treats people with insomnia, nightmares, body clock disorders, restless legs, sleep paralysis and related disorders.
-
Whether to check appointment details, receive test results and clinic letters, or to complete pre-visit questions and checks to prepare for appointments, more and more patients activate MyCare UCLH each day.
-
This has been written by the acupuncture team at the Royal London Hospital for Integrated Medicine ( It gives you information about how to do home- acupuncture and how to manage any possible side effects.
-
This patient information explains what Aural (ear) microsuction is and what your alternatives are.
-
This page explains how to start using a breast pump.
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment